US · Healthcare

Satellos Bioscience Inc (MSCLF)

Biotechnology

Satellos Bioscience Inc (MSCLF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MSCLF

P/E ratio

25.00

Satellos Bioscience Inc (MSCLF) — FAQ

What is MSCLF's P/E ratio?

The price-to-earnings (P/E) ratio for Satellos Bioscience Inc (MSCLF) is 25.00 (data as of 2026-05-23).

Does Satellos Bioscience Inc pay a dividend?

Dividend yield is not available in the current snapshot for Satellos Bioscience Inc (MSCLF). Check the MyAverix Finance app for the latest dividend data.

What sector is Satellos Bioscience Inc in?

Satellos Bioscience Inc (MSCLF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MSCLF listed on?

MSCLF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)